Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_assertion type Assertion NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_head.
- NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_assertion description "[Gain-of-function mutations in NOTCH1 are common in T-cell lymphoblastic leukemias and lymphomas (T-ALL), making this receptor a promising target for drugs such as gamma-secretase inhibitors, which block a proteolytic cleavage required for NOTCH1 activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_provenance.
- NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_assertion evidence source_evidence_literature NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_provenance.
- NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_assertion SIO_000772 17873882 NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_provenance.
- NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_assertion wasDerivedFrom befree-20140225 NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_provenance.
- NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_assertion wasGeneratedBy ECO_0000203 NP800610.RAg7Ag9SaFU3KJQi-LZMYXwCjZV5OCda7KAxCs6WPBWE0130_provenance.